Company page
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. is a public company traded under the ticker RNAC in the American market. The company has a market capitalization of approximately $231.5 million. Cartesian Therapeutics focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- RNAC:NASDAQ
- Asset type
- Stock
- Market cap
- $247.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD